Vesalius Biocapital Partners and SRIW have led a €10m funding round in Belgian pharmaceuticals company Euroscreen.
Other investors in the round included Life Sciences Research Partners VZW, Societe de Participation et de Gestion, Hunza Ventures and existing shareholders Fortis Private Equity, Compagnie du Bois Sauvage,...
Catch up on essential features from this past week with our round-up of industry analysis
As part of the deal, the GP will acquire a majority stake in the Italian coffee machien maker
Deal marks Riverside's fifth buyout this year and its first in Germany in 2016
Latest round brings total funding received by company to €13.5m